All in at every level
Much goes in to creating treatments and cures for Rett syndrome. IRSF’s investments have already produced game-changing discoveries and built essential treatment development infrastructure. Our leadership and support direct Rett research along a path to treatment and cures for all individuals with Rett.
IRSF’s Scientific Strategy consists of three guiding pillars that cover Rett research at every level:
- Critical research– Critical research addresses gaps in researchers’ knowledge of Rett syndrome, including MECP2 and other targets that give rise to the pathology of Rett. It equips researchers with the information they need to devise new ways to treat Rett and improve upon existing ones.
- Pipeline development– The Rett treatment development pipeline represents the assessments potential new treatments undergo to prepare for testing in clinical trials. IRSF works to improve the pipeline while helping companies developing Rett treatments to navigate it.
- Clinical trials– IRSF supports Rett clinical trials through facilitating communication and connection among the clinical trial stakeholders: Rett families, physicians, the FDA, and trial sponsors. At the same time, it invests in the infrastructure necessary for successful clinical trials such as Rett registries and research on
Check out our latest funded research aimed at providing life-changing treatments and a cure.
Rett Syndrome Registry
Learn how IRSF is helping to increase clinical trial success to bring curative treatment options to families.
Rett Research Ready
Find a clinical trial or study and learn how you can become a partner in research.
The Steven G. Kaminsky Scout Program accelerates research by testing new and repurposed compounds for potential use in Rett syndrome.
Natural History Study
The Natural History Study is the most comprehensive study of Rett syndrome in the world.
Rett Syndrome Centers of Excellence
We partner with 22 Rett syndrome clinics across North America to provide care and treatment to those with Rett syndrome and participate in our North American Rett syndrome Clinics Network. The International Rett Syndrome Foundation has created an innovative clinic program designation, the IRSF Centers of Excellence for US clinics that meet rigorous criteria and provide exceptional care to those with Rett syndrome.
We also recognize the 14 US clinics that have been involved with the NIH funded Natural History Study for their long commitment to studying and improving the lives of those who suffer from Rett syndrome.
Rett Clinics Participating in NIH-Funded Natural History Study
University of Alabama Birmingham Civitan International Research Center, Birmingham, AL
University of California San Diego, Rady Children’s Hospital, San Diego, CA
University of California San Francisco Benioff Children’s Hospital Oakland, Walnut Creek, CA
Children’s Hospital Colorado, Aurora, CO
Rush University Medical Center, Chicago, IL
Boston Children’s Hospital and Harvard Medical School, Boston, MA
Gillette Children’s Specialty Healthcare, Saint Paul, MN
Washington University School of Medicine Saint Louis Children’s Hospital, Saint Louis, MO
University of Rochester Medical Center, Rochester, NY
Cincinnati Children’s Hospital Medical Center, Cincinnati, OH
Children’s Hospital of Philadelphia, Philadelphia, PA
Greenwood Genetic Center, Greenwood, SC
Vanderbilt University School of Medicine and Vanderbilt Kennedy Center for Research on Human Development, Nashville, TN
Texas Children’s Hospital, The Blue Bird Circle Rett Center, Houston, TX